Cita APA

Cuppini, L., Calleri, A., Bruzzone, M. G., Prodi, E., Anghileri, E., Pellegatta, S., . . . Eoli, M. (2013). Prognostic Value of CD109+ Circulating Endothelial Cells in Recurrent Glioblastomas Treated with Bevacizumab and Irinotecan. Public Library of Science.

Chicago Style Citation

Cuppini, Lucia, et al. Prognostic Value of CD109+ Circulating Endothelial Cells in Recurrent Glioblastomas Treated With Bevacizumab and Irinotecan. Public Library of Science, 2013.

Cita MLA

Cuppini, Lucia, et al. Prognostic Value of CD109+ Circulating Endothelial Cells in Recurrent Glioblastomas Treated With Bevacizumab and Irinotecan. Public Library of Science, 2013.